TANG CAPITAL MANAGEMENT LLC - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 24 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TANG CAPITAL MANAGEMENT LLC ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q1 2015$1,132,000
+1032.0%
1,572,699
+3031.7%
0.60%
+1057.7%
Q3 2014$100,000
+28.2%
50,219
+175.2%
0.05%
+36.8%
Q1 2014$78,00018,2450.04%
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q1 2015
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,572,699$1,132,0000.60%
Broadfin Capital, LLC 1,126,482$811,0000.06%
Bison Wealth, LLC 34,310$25,0000.02%
TOCQUEVILLE ASSET MANAGEMENT L.P. 125,000$90,0000.00%
NOMURA HOLDINGS INC 41,900$30,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 1,998$1,439,0000.00%
BANK OF AMERICA CORP /DE/ 14,000$10,0000.00%
WELLS FARGO & COMPANY/MN 10$00.00%
NORTHERN TRUST CORP 15,535$11,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 83,565$60,0000.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders